Taiho’s DMD asset fails to improve functional motor test results in phase 3 trial
Concentra extends biotech shopping spree by collecting Cargo
CSL trims R&D team, shifts focus toward external opportunities
Rallybio shifts gears, cashing out of Recursion pact to extend runway
ProKidney’s CKD cell therapy scores win in one half of phase 2 trial, falls short on other
Novartis' malaria drug for babies wins world-first approval
Cell therapy biotech shares first clinical data for in vivo CAR-T that attracted $1B AstraZeneca acquisition
Basilea secures $39M from BARDA as part of long-term antifungal funding plan